DDD-028
DDD-028 is a potent non-opioid, non-cannabinoid analgesic which attenuates neuropathic and inflammatory pain without the possible side effects or abuse potential associated with opioid or cannabinoid activities. DDD-028 can be utilized in analgesic research[1].
Product Specifications
CAS Number
1538586-09-2
UNSPSC
12352005
Target
Opioid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ddd-028.html
Smiles
CN(CC1)CC2=C1N(CC3)C4=C2C=CC=C4C5=C3C=CC=C5
Molecular Formula
C20H20N2
Molecular Weight
288.39
References & Citations
[1]Rajagopalan P, et al. DDD-028: a potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain. Bioorg Med Chem Lett. 2014 Jul 15;24 (14) :3088-91.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-11815R-BF750-TR 20 µL
CBLN2 Polyclonal Antibody, AbBy Fluor™ 750 Conjugated
Sign In for Pricing
View Details 
OR1100699-01 250 mg
1- (3-Bromo-5-methoxyphenyl) -2-chloro-1-propanone
Sign In for Pricing
View Details OR1100699-02 500 mg
1- (3-Bromo-5-methoxyphenyl) -2-chloro-1-propanone
Sign In for Pricing
View Details OR1100699-03 1 g
1- (3-Bromo-5-methoxyphenyl) -2-chloro-1-propanone
Sign In for Pricing
View Details MBS6187623-01 0.1 mL
CDH11 (Cadherin 11, Type 2, OB-Cadherin (Osteoblast), CAD11, CDHOB, OB, OSF-4) (PE)
Sign In for Pricing
View Details